We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sensor Patch Accurately Detects Atrial Fibrillation

By HospiMedica International staff writers
Posted on 24 Nov 2021
An easy-to-use long-term electrocardiogram (ECG) sensor allows continuous outpatient recording of heart rhythms, with the diagnostic accuracy of a Holter monitor.

The Appsens AS (Lillesand, Norway) ECG247 heart sensor is a wireless single-lead ECG monitor that consists of an electrode patch with a lightweight reusable sensor, a smartphone application, a back-end cloud service, and a web portal. More...
The water-resistant sensor attaches over the sternum and continuously monitors heart rhythm for up to 14 days without the need for charging. All ECG recordings are sent via Bluetooth Low Energy (BLE) communication through an app on the patient’s mobile phone to secure Microsoft Azure cloud storage, with web-access for the user and for healthcare professionals.

The ECG247 algorithms automatically detect and categorize cardiac arrhythmias using a multiple-step algorithm that analyzes the QRS complex as an adaptive process to ensure reliable detection; identify the correct beat type, based on a machine-learning algorithm that distinguishes between normal beats, supraventricular beats, ventricular beats, and artefacts; and analyze the arrhythmias or changes in rhythm to detect atrial flutter (AF), low/high heart rate, supraventricular tachycardia, ventricular tachycardia, and pauses.

“By detecting heart rhythm disorders early, ECG247 can help prevent serious complications such as stroke; 50,000 people [in Norway] with heart fibrillation are not aware of this because they have no symptoms,” said Tord Ytterdahl, managing director of Appsens AS. “At the moment, there is no product with the right technology that captures the large group of people who have this. Many people who feel palpitations from time to time can now easily test themselves.”

The original Holter monitor, named for physicist Norman J. Holter who invented telemetric cardiac monitoring in 1949, is a portable device for continuously monitoring various electrical activity of the cardiovascular system for at least 24 hours (often for two weeks at a time). Its extended recording period is useful for observing occasional cardiac arrhythmias which would be difficult to identify in a shorter period of time.

Related Links:
Appsens AS


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.